Skip NavigationSkip to Content

Expression, purification, refolding, and characterization of recombinant human interleukin-13: Utilization of intracellular processing

  1. Author:
    Eisenmesser, E. Z.
    Kapust, R. B.
    Nawrocki, J. P.
    Mazzulla, M. J.
    Pannell, L. K.
    Waugh, D. S.
    Byrd, R. A.
  2. Author Address

    NCI, Frederick Canc Res & Dev Ctr, Macromol NMR Sect, Struct Biophys Lab, Frederick, MD 21702 USA. NCI, Frederick Canc Res & Dev Ctr, Macromol NMR Sect, Struct Biophys Lab, Frederick, MD 21702 USA. NCI, Frederick Canc Res & Dev Ctr, Prot Engn Sect, Macromol Crystallog Lab, Frederick, MD 21702 USA. NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA.
    1. Year: 2000
  1. Journal: Protein Expression and Purification
    1. 20
    2. 2
    3. Pages: 186-195
  2. Type of Article: Article
  1. Abstract:

    Interleukin-13 (IL-13) is a pleiotropic cytokine that elicits both proinflammatory and anti-inflammatory immune responses. Recent studies underscore its role in several diseases, including asthma and cancer. Solution studies of IL-13 and its soluble receptors may facilitate the design of antagonists/agonists which would require milligram quantities of specifically labeled protein. A synthetic gene encoding human IL-13 (hIL-13) was inserted into the pMAL-c2 vector with a cleavage site for the tobacco etch virus (TEV) protease. Coexpression of the fusion protein and TEV protease led to in vivo cleavage, resulting in high levels of hIL-13 production. hIL-13, localized to inclusion bodies, was purified and refolded to yield approximately 2 mg per liter of bacteria grown in minimal media. Subsequent biochemical and biophysical analysis of both the unlabeled and N-15-labeled protein revealed a bioactive helical monomer. In addition, the two disulfide bonds were unambiguously demonstrated to be Cys29- Cys57 and Cys45-Cys71 by a combined proteolytic digestion and mass spectrometric analysis. (C) 2000 Academic Press.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel